Pathogenic mechanisms in varicose vein disease: The role of hypoxia and inflammation

Pathology

Volumn 42, Issue 5, 2010, Pages 446-453

  Hossein Ghaderian, Sayyed Mohammad ^a   Lindsey, Nigel J ^b   Graham, Anne M ^b   Homer Vanniasinkam, Shervanthi ^b   Najar, Reza Akbarzadeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Adhesion molecules; Endothelial cell; Hypoxia; Hypoxia inducible factor 1 alpha; Varicose vein disease

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA;

ADULT; AGED; CELL HYPOXIA; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INTIMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHLEBITIS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; ULTRASTRUCTURE; VARICOSIS; VASCULAR ENDOTHELIUM;

ADULT; AGED; CELL HYPOXIA; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PHLEBITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPHENOUS VEIN; TUNICA INTIMA; VARICOSE VEINS;

EID: 77954787816     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313025.2010.493865     Document Type: Article

References (58)

1. Badier-Commander C, Couvelard A, Henin D, Verbeuren T, Michel JB, Jacob MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001; 193: 398-407.
2. Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg (Torino) 1986; 27: 534-543
3. Hollingsworth SJ, Tang CB, Barker SGE. Primary varicose veins in the presence of an intact sapheno-femoral junction. Phlebology 2001; 16: 68-72.
4. Abu-Own A, Scurr JH, Coleridge Smith PD. Saphenous vein reflux without incompetence at the saphenofemoral junction. Br J Surg 1994; 81: 1452-1454
5. Haimovici H. Role of precapillary arteriovenous shunting in the pathogenesis of varicose veins and its therapeutic implications. Surgery 1987; 101: 515-522
6. Blochl-Daum B, Schuller-Petrovic S, Wolzt M, Korn A, Bohler K, Eichler HG. Primary defect in alpha-adrenergic responsiveness in patients with varicose veins. Clin Pharmacol Ther 1991; 49: 49-52.
7. Thulesius O, Said S, Shuhaiber H, Neglen P, Gjores JE. Endothelial mediated enhancement of noradrenaline induced vasoconstriction in normal and varicose veins. Clin Physiol 1991; 11: 153-159
8. Schuller-Petrovic S, Siedler S, Kern T, Meinhart J, Schmidt K, Brunner F. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis. Br J Pharmacol 1997; 122: 772-778
9. Hofer H, Mihatsch MJ, Guggenheim R, Amsler B, Hasse J, Graedel E. Morphologic studies in saphenous vein grafts for aorto-coronary bypass surgery. Part I: Morphology of the Graft using ordinary surgical preparation techniques. Thorac Cardiovasc Surg 1981; 29: 32-37 (Pubitemid 11138482)
10. Wali MA, Eid RA. Intimal changes in varicose veins: An ultrastructural study. J Smooth Muscle Res 2002; 38: 63-74.
11. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006; 55: 113-118
12. Hamada J, Yano S, Kai Y, et al. Histopathological study of venous aneurysms in patients with dural arteriovenous fistulas. J Neurosurg 2000; 92: 1023-1027
13. Folse R. The influence of femoral vein dynamics on the development of varicose veins. Surgery 1970; 68: 974-979
14. Clarke GH, Vasdekis SN, Hobbs JT, Nicolaides AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992; 111: 402-408
15. Ludbrook J. Primary great saphenous varicose veins revisited. World J Surg 1986; 10: 954-958
16. Zelikovski A, Zamir B, Hadar H, Urca I. Sapheno-femoral valve insufficiency in varicose veins of the lower limb. Angiology 1981; 32: 807-811
17. Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997; 16: 134-141
18. Porto LC, da Silveira PR, de Carvalho JJ, Panico MD. Connective tissue accumulation in the muscle layer in normal and varicose saphenous veins. Angiology 1995; 46: 243-249
19. Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 1999; 94: 4177-4185
20. Caniggia I, Mostachfi H, Winter J, et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 2000; 105: 577-587
21. Eckhart AD, Yang N, Xin X, Faber JE. Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 1997; 94: 9487-9492
22. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613
23. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997; 272: 23659-23667
24. Cormier-Regard S, Nguyen SV, Claycomb WC. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998; 273: 17787-17792
25. Hu J, Discher DJ, Bishopric NH, Webster KA. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxiainducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 1998; 245: 894-899
26. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995; 182: 1683-1693
27. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF- 1. Am J Physiol 1998; 274: L212-9.
28. Lee PJ, Jiang BH, Chin BY, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375-5381
29. Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000; 14: 427-435
30. Michiels C, Bouaziz N, Remacle J. Role of the endothelium and blood stasis in the appearance of varicose veins. Int Angiol 2002; 21: 1-8. (Pubitemid 34413648)
31. Ciuffetti G, Lombardini R, Pasqualini L, Vaudo G, Lupattelli G. Circulating leucocyte adhesion molecules in chronic venous insufficiency. Vasa 1999; 28: 156-159
32. Coleridge-Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 2001; 52 (Suppl 1): S35-42.
33. Stvrtinova V, Jahnova E, Weissova S, Horvathova M, Ferencik M. Inflammatory mechanisms involving neutrophils in chronic venous insufficiency of lower limbs. Bratisl Lek Listy 2001; 102: 235-239
34. Aunapuu M, Arend A. Histopathological changes and expression of adhesion molecules and laminin in varicose veins. Vasa 2005; 34: 170-175
35. Khan AA, Eid RA, Hamdi A. Structural changes in the tunica intima of varicose veins: A histopathological and ultrastructural study. Pathology 2000; 32: 253-257
36. Charles AK, Gresham GA. Histopathological changes in venous grafts and in varicose and non-varicose veins. J Clin Pathol 1993; 46: 603-606
37. Milroy CM, Scott DJ, Beard JD, Horrocks M, Bradfield JW. Histological appearances of the long saphenous vein. J Pathol 1989; 159: 311-316
38. Ito N, Takeshita A, Higuchi S, Nakamura M. Venous abnormality in normotensive young men with a family history of hypertension. Hypertension 1986; 8: 142-146
39. Mark AL. Structural changes in resistance and capacitance vessels in borderline hypertension. Hypertension 1984; 6: III69-73.
40. Mulvany MJ. Peripheral vasculature in essential hypertension. Clin Exp Pharmacol Physiol 1996; 23: S6-10.
41. Heistad DD, Lopez JA, Baumbach GL. Hemodynamic determinants of vascular changes in hypertension and atherosclerosis. Hypertension 1991; 17 (4 Suppl): III7-11.
42. Mashiah A, Rose SS, Hod I. The scanning electron microscope in the pathology of varicose veins. Isr J Med Sci 1991; 27: 202-206
43. Obitsu Y, Ishimaru S, Furukawa K, Yoshihama I. Histopathological studies of the valves of varicose veins. Phlebology 1990; 5: 245-254
44. Corcos L, De Anna D, Dini M, Macchi C, Ferrari PA, Dini S. Proximal long saphenous vein valves in primary venous insufficiency: Histopathology and pathophysiological implications. J Mal Vasc 2000; 25: 27-36.
45. Leu HJ, Vogt M, Pfrunder H. Morphological alterations of nonvaricose and varicose veins. (A morphological contribution to the discussion on pathogenesis of varicose veins). Basic Res Cardiol 1979; 74: 435-444
46. Arnould T, Michiels C, Janssens D, Berna N, Remacle J. Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human saphenous vein endothelium. J Cardiovasc Pharmacol 1998; 31: 456-463 (Pubitemid 28103627)
47. Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33: 7-11.
48. Coleridge Smith PD. The microcirculation in venous hypertension. Vasc Med 1997; 2: 203-213
49. Ruiz-Deya G, Sikka SC, Thomas R, Abdel-Mageed AB. Potential role for the nuclear transcription factor NF-kappa B in the pathogenesis of ureteropelvic junction obstruction. J Endourol 2002; 16: 611-615
50. Ohga E, Nagase T, Tomita T, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87: 10-14
51. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94: 179-184
52. Ohga E, Matsuse T. The relationship between adhesion molecules and hypoxia. (Japanese.) Nippon Rinsho 2000; 58: 1587-1591
53. Hollingsworth SJ, Powell G, Barker SG, Cooper DG. Primary varicose veins: Altered transcription of VEGF and its receptors (KDR, flt-1, soluble flt-1) with sapheno-femoral junction incompetence. Eur J Vasc Endovasc Surg 2004; 27: 259-268
54. Saharay M, Shields DA, Georgiannos SN, Porter JB, Scurr JH, Coleridge Smith PD. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998; 15: 342-349 (Pubitemid 28205994)
55. Chester AH, Borland JA, Taylor PM, Rose ML, Yacoub MH. Vascular adhesion molecules and immunogenicity in blood vessels used as coronary artery bypass grafts. Eur J Cardiothorac Surg 1996; 10: 676-683
56. Chester AH, Morrison KJ, Yacoub MH. Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thorac Surg 1998; 65: 1685-1689
57. Satokawa H, Hoshino S, Igari T, Iwaya F, Midorikawa H. The appearance of cytokines and adhesion molecules in saphenous vein valves in chronic venous insufficiency. Phelebology 2002; 16: 106-110
58. Travers JP, Brookes CE, Evans J, et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996; 11: 230-237